SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trillium Therapeutics
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
294 40 0 TRIL
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
44BRD inhibitors in ---breast cancer: BET Bromodomain versus TNBC The Fluorinov tuck-4/13/2016
43Digging around for stuff at AACR, I came across Novimmune's bi-specific antituck-3/23/2016
42Along with the BET project, the next generation proteasome inhibitor looks intertuck-1/27/2016
41Fluorinov: lots of NPS people. The CSO was involved in the mGluR program, whichtuck-1/27/2016
40Bromodomain inhibition in oncology is the bailiwick of several players. I mentituck11/27/2016
39>> H/T to dewophile on IHub for starting that process << Yes, veryscaram(o)uche-1/27/2016
38>>I am tempted to call up and ask if they are seeing any interest in theituck11/27/2016
37Thanks for the link! The trial is open label, we could get reports on the very scaram(o)uche-1/26/2016
36>> I'm not seeing near term catalysts, so trading it technically.<tuck-1/26/2016
35interesting..... Proc Natl Acad Sci U S A. 2015 Oct 28. pii: 201520032. [Epub ascaram(o)uche-11/2/2015
34And unloaded at $15.25. I'm not seeing near term catalysts, so trading it ttuck-11/2/2015
33Reloaded a nibble ~$13. Cheers, Tucktuck-9/28/2015
32>>Upregulation of CD200 is associated with regulatory T cell expansion andtuck-9/1/2015
31CD47 blockade triggers T cell–mediated destruction of immunogenic tumors Xiaojuscaram(o)uche-9/1/2015
30Mixed shelf, warrants/units.scaram(o)uche-5/29/2015
29I'll take a look at your links. You know how much I enjoy reading patents. scaram(o)uche-4/20/2015
28>> pretty impactful << On delta, percent market cap? Certainly notscaram(o)uche-4/20/2015
27"The abstract doesn't give warm and fuzzies, eh?..... lots of time spentuck-4/19/2015
26Slam bam thank you sir. Given ronponeil, Peter, and your select pointers, we noscaram(o)uche-4/19/2015
25This year's AACR abstract delves into the mechanism behind SIRPaFc's pootuck-4/19/2015
24>> “It's a big sucker...” Tuck: Could you clarify what you mean by “bBulbaMan-3/12/2015
23Trillium filed a prospectus today: Prospectus It's a big sucker, but worthtuck-3/12/2015
22FWIW, sold position for a double. Remain interested on pullbacks. Cheers, Tuctuck-2/25/2015
21Blockade of CD47 Using SIRPaFc: Role of the Fc Region in Anti-Leukemic Activity tuck-12/19/2014
20Chuckle. I was trying to determine, this morning, where it was that I had seen scaram(o)uche-12/19/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):